| http://www.w3.org/ns/prov#value | - This press release contain forward looking statements, including statements regarding Telik's anticipated cash reserves, ability to secure additional funding or complete partnering, licensing or other strategic transactions, the future development of TELINTRA, preclinical drug candidates and potential corporate partnerships.
|
